Synthesis, antimicrobial and antiviral activity of substituted benzimidazoles. 2009

Deepika Sharma, and Balasubramanian Narasimhan, and Pradeep Kumar, and Vikramjeet Judge, and Rakesh Narang, and Erik De Clercq, and Jan Balzarini
Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science and Technology, Hisar 125001, India.

In the present study we have synthesized (4-nitrophenyl)-[2-(substituted phenyl)-benzoimidazol-1-yl]-methanones, (2-bromophenyl)-[2-(substituted phenyl)-benzoimidazol-1-yl]-methanone analogues (1-14) and evaluated them for their antimicrobial and antiviral potential. The results of antimicrobial screening indicated that none of the synthesized compounds were effective against the tested bacterial strains. Compounds 3, 11, 13 and compounds 5, 11, 12 were found to be active against Aspergillus niger and Candida albicans respectively, and may be further developed as antifungal agents. Furthermore, evaluation against a panel of different viruses pointed out the selective activity of compounds 5 and 6 against vaccinia virus and Coxsackie virus B4.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005658 Fungi A kingdom of eukaryotic, heterotrophic organisms that live parasitically as saprobes, including MUSHROOMS; YEASTS; smuts, molds, etc. They reproduce either sexually or asexually, and have life cycles that range from simple to complex. Filamentous fungi, commonly known as molds, refer to those that grow as multicellular colonies. Fungi, Filamentous,Molds,Filamentous Fungi,Filamentous Fungus,Fungus,Fungus, Filamentous,Mold
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria
D001562 Benzimidazoles Compounds with a BENZENE fused to IMIDAZOLES.

Related Publications

Deepika Sharma, and Balasubramanian Narasimhan, and Pradeep Kumar, and Vikramjeet Judge, and Rakesh Narang, and Erik De Clercq, and Jan Balzarini
July 2007, Bioorganic & medicinal chemistry,
Deepika Sharma, and Balasubramanian Narasimhan, and Pradeep Kumar, and Vikramjeet Judge, and Rakesh Narang, and Erik De Clercq, and Jan Balzarini
June 2001, European journal of medicinal chemistry,
Deepika Sharma, and Balasubramanian Narasimhan, and Pradeep Kumar, and Vikramjeet Judge, and Rakesh Narang, and Erik De Clercq, and Jan Balzarini
May 2015, Drug research,
Deepika Sharma, and Balasubramanian Narasimhan, and Pradeep Kumar, and Vikramjeet Judge, and Rakesh Narang, and Erik De Clercq, and Jan Balzarini
June 1982, Die Pharmazie,
Deepika Sharma, and Balasubramanian Narasimhan, and Pradeep Kumar, and Vikramjeet Judge, and Rakesh Narang, and Erik De Clercq, and Jan Balzarini
January 1999, Metal-based drugs,
Deepika Sharma, and Balasubramanian Narasimhan, and Pradeep Kumar, and Vikramjeet Judge, and Rakesh Narang, and Erik De Clercq, and Jan Balzarini
June 1996, Farmaco (Societa chimica italiana : 1989),
Deepika Sharma, and Balasubramanian Narasimhan, and Pradeep Kumar, and Vikramjeet Judge, and Rakesh Narang, and Erik De Clercq, and Jan Balzarini
December 1997, Archiv der Pharmazie,
Deepika Sharma, and Balasubramanian Narasimhan, and Pradeep Kumar, and Vikramjeet Judge, and Rakesh Narang, and Erik De Clercq, and Jan Balzarini
May 2018, Pakistan journal of pharmaceutical sciences,
Deepika Sharma, and Balasubramanian Narasimhan, and Pradeep Kumar, and Vikramjeet Judge, and Rakesh Narang, and Erik De Clercq, and Jan Balzarini
July 1980, Journal of medicinal chemistry,
Deepika Sharma, and Balasubramanian Narasimhan, and Pradeep Kumar, and Vikramjeet Judge, and Rakesh Narang, and Erik De Clercq, and Jan Balzarini
February 1982, Archiv der Pharmazie,
Copied contents to your clipboard!